Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

Raymond James Maintains Outperform on Capri Holdings, Lowers Price Target to $60

By Benzinga Newsdesk

Today, 9:51 AM

Raymond James analyst Rick Patel maintains Capri Holdings (NYSE:CPRI) with a Outperform and lowers the price target from $73 to $60.

CPRI

Here’s Why Roku Plunged Below 52-Week Low Today

By Anusuya Lahiri

Today, 9:51 AM

Analysts slashed their price targets on Roku Inc (NASDAQ:ROKU) post Q4 results. Pivotal Research analyst Jeffrey Wlodarczak downgraded to Sell from Hold with a…

ROKU

Morgan Stanley Maintains Equal-Weight on CF Industries Holdings, Raises Price Target to $100

By Benzinga Newsdesk

Today, 9:51 AM

Morgan Stanley maintains CF Industries Holdings (NYSE:CF) with a Equal-Weight and raises the price target from $66 to $100.

Morgan Stanley Maintains Overweight on Ross Stores, Raises Price Target to $139

By Benzinga Newsdesk

Today, 9:51 AM

Morgan Stanley maintains Ross Stores (NASDAQ:ROST) with a Overweight and raises the price target from $137 to $139.

ROST

Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Related Posts

Raymond James Maintains Outperform on Capri Holdings, Lowers Price Target to $60

Here’s Why Roku Plunged Below 52-Week Low Today

Morgan Stanley Maintains Equal-Weight on CF Industries Holdings, Raises Price Target to $100

Morgan Stanley Maintains Overweight on Ross Stores, Raises Price Target to $139